Edwards Lifesciences(EW+1.7%) says a U.S. Appeals Court has affirmed a 2010 federal jury decision that Medtronic (MDT+0.3%) is infringing the company's U.S. Andersen transcatheter heart valve patent, as well as an initial payment award to EW of $74M. The court also ordered the trial court to reconsider EW's request for a permanent injunction that would prohibit the sale of Medtronic's CoreValve system in the U.S.